Diabetic Foot Ulcer Therapeutics Market Size and Trends Analysis
The global diabetic foot ulcer therapeutics market size is projected to rise from US$ 7,578.5 Mn in 2025 to US$ 11,246.8 Mn by 2032. It is anticipated to exhibit a CAGR of 5.8% during the forecast period from 2025 to 2032.
Diabetic Foot Ulcer (DFU) has become an important public health concern, leading to a lower quality of life, high healthcare expenditure, and long hospital stays for patients with diabetes. As per Persistence Market Research, the condition is considered a key complication in those living with type 2 diabetes, affecting around 20% of patients. Increasing global prevalence of diabetes, especially in middle- and low-income countries, has surged the cases of DFUs, bolstering demand for therapeutic interventions.